James Zacny to Cohort Studies
This is a "connection" page, showing publications James Zacny has written about Cohort Studies.
Connection Strength
0.025
-
Phase I Study of Aurora A Kinase Inhibitor Alisertib (MLN8237) in Combination With Selective VEGFR Inhibitor Pazopanib for Therapy of Advanced Solid Tumors. Am J Clin Oncol. 2019 05; 42(5):413-420.
Score: 0.025